Literature DB >> 28598907

Treating pain on skin graft donor sites: Review and clinical recommendations.

Sarthak Sinha1, Amanda J Schreiner, Jeff Biernaskie, Duncan Nickerson, Vincent A Gabriel.   

Abstract

Split-thickness skin grafting is the most common reconstructive procedure in managing burn injuries. Harvesting split-thickness skin creates a new partial thickness wound referred to as the donor site. Pain at the donor site is reported to be one of the most distressing symptoms during the early postoperative period. Here, we (a) identify strategies for managing donor site pain, (b) assess the quality of individual studies, and (c) formulate evidence-based recommendations based on the amount and consistency of evidence. Our analysis revealed five distinct approaches to minimize donor site pain. These include: continuous subcutaneous local anesthetic infusion (three studies), subcutaneous anesthetic injection (five studies), topical agents (six studies), nonpharmacological interventions (three studies), and wound dressings (18 studies). Available randomized control trials typically evaluated pain on standardized scales (i.e. Visual Analog Scale, Numerical Rating Scale), and compared the experimental group with standard care. Recommended treatments include: (a) subcutaneous anesthetic injection of adrenaline-lidocaine; (b) ice application; (c) topical agents, such as lidocaine and bupivacaine; and (d) hydrocolloid- and polyurethane-based wound dressings accompanied with fibrin sealant. Methodologically sound randomized control trials examining the efficacy of modified tumescent solution, ropivacaine, plasma therapy, noncontact ultrasound, and morphine gels are lacking and should be a priority for future research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28598907     DOI: 10.1097/TA.0000000000001615

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  8 in total

Review 1.  Regional Anesthetic Blocks for Donor Site Pain in Burn Patients: A Meta-Analysis on Efficacy, Outcomes, and Cost.

Authors:  Katherine A Grunzweig; Ji Son; Anand R Kumar
Journal:  Plast Surg (Oakv)       Date:  2020-06-10       Impact factor: 0.947

2.  Dorsolateral prefrontal cortex sensing analgesia.

Authors:  Etsuro Ito; Kotaro Oka; Fusako Koshikawa
Journal:  Biophys Physicobiol       Date:  2022-04-08

3.  Pain relief associated with decreased oxyhemoglobin level in left dorsolateral prefrontal cortex.

Authors:  Shun Miyashiro; Yurika Yamada; Masaru Nagaoka; Rei Shima; Toshizumi Muta; Haruyuki Ishikawa; Tetsuri Abe; Masashi Hori; Kotaro Oka; Fusako Koshikawa; Etsuro Ito
Journal:  PLoS One       Date:  2021-08-23       Impact factor: 3.240

4.  Evaluation of Donor Site Pain After Fractional Autologous Full-Thickness Skin Grafting.

Authors:  Jose A Jaller; Ingrid Herskovitz; Luis J Borda; Joshua Mervis; Evan Darwin; Penelope A Hirt; Hadar Lev-Tov; Robert S Kirsner
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-09-04       Impact factor: 4.730

Review 5.  Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls.

Authors:  Marie-Line Reynaert; Denis Dupoiron; Edouard Yeramian; Laurent Marsollier; Priscille Brodin
Journal:  Toxins (Basel)       Date:  2019-09-04       Impact factor: 4.546

6.  Multi-faceted enhancement of full-thickness skin wound healing by treatment with autologous micro skin tissue columns.

Authors:  Christiane Fuchs; Linh Pham; Jermaine Henderson; Katherine J Stalnaker; R Rox Anderson; Joshua Tam
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

7.  Curing Necrotic Angiodermatitis with an Intact Fish Skin Graft in a Patient Living with Diabetes.

Authors:  Dured Dardari; Corinne Lequint; Anne Christine Jugnet; Tatiana Bénard; Marie Bouly; Alfred Penfornis
Journal:  Medicina (Kaunas)       Date:  2022-02-15       Impact factor: 2.430

8.  Use of oxidized regenerated cellulose (ORC)/collagen/silver-ORC dressings to help manage skin graft donor site wounds.

Authors:  Saeed A Chowdhry
Journal:  JPRAS Open       Date:  2019-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.